Literature DB >> 26189426

Robust In Vitro Induction of Human Germ Cell Fate from Pluripotent Stem Cells.

Kotaro Sasaki1, Shihori Yokobayashi2, Tomonori Nakamura1, Ikuhiro Okamoto1, Yukihiro Yabuta1, Kazuki Kurimoto1, Hiroshi Ohta1, Yoshinobu Moritoki3, Chizuru Iwatani4, Hideaki Tsuchiya4, Shinichiro Nakamura4, Kiyotoshi Sekiguchi5, Tetsushi Sakuma6, Takashi Yamamoto6, Takahide Mori7, Knut Woltjen8, Masato Nakagawa9, Takuya Yamamoto10, Kazutoshi Takahashi9, Shinya Yamanaka9, Mitinori Saitou11.   

Abstract

Mechanisms underlying human germ cell development are unclear, partly due to difficulties in studying human embryos and lack of suitable experimental systems. Here, we show that human induced pluripotent stem cells (hiPSCs) differentiate into incipient mesoderm-like cells (iMeLCs), which robustly generate human primordial germ cell-like cells (hPGCLCs) that can be purified using the surface markers EpCAM and INTEGRINα6. The transcriptomes of hPGCLCs and primordial germ cells (PGCs) isolated from non-human primates are similar, and although specification of hPGCLCs and mouse PGCs rely on similar signaling pathways, hPGCLC specification transcriptionally activates germline fate without transiently inducing eminent somatic programs. This includes genes important for naive pluripotency and repression of key epigenetic modifiers, concomitant with epigenetic reprogramming. Accordingly, BLIMP1, which represses somatic programs in mice, activates and stabilizes a germline transcriptional circuit and represses a default neuronal differentiation program. Together, these findings provide a foundation for understanding and reconstituting human germ cell development in vitro.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26189426     DOI: 10.1016/j.stem.2015.06.014

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  158 in total

1.  Recommended Ethical Safeguards on Fertilization of Human Germ Cells Derived from Pluripotent Stem Cells Solely for Research Purposes.

Authors:  Hiroshi Mizuno
Journal:  Stem Cell Rev Rep       Date:  2016-08       Impact factor: 5.739

2.  Reconstitution of mouse oogenesis in a dish from pluripotent stem cells.

Authors:  Katsuhiko Hayashi; Orie Hikabe; Yayoi Obata; Yuji Hirao
Journal:  Nat Protoc       Date:  2017-08-10       Impact factor: 13.491

3.  Reconstitution in vitro of the entire cycle of the mouse female germ line.

Authors:  Orie Hikabe; Nobuhiko Hamazaki; Go Nagamatsu; Yayoi Obata; Yuji Hirao; Norio Hamada; So Shimamoto; Takuya Imamura; Kinichi Nakashima; Mitinori Saitou; Katsuhiko Hayashi
Journal:  Nature       Date:  2016-10-17       Impact factor: 49.962

4.  Signals and transcription factors for specification of human germ cells.

Authors:  Sina Jostes; Hubert Schorle
Journal:  Stem Cell Investig       Date:  2018-04-29

5.  Evolutionarily diverse mechanisms of germline specification among mammals: what about us?

Authors:  Shino Mitsunaga; Toshi Shioda
Journal:  Stem Cell Investig       Date:  2018-04-24

6.  A step toward making human oocytes.

Authors:  Jessica M Stringer; Patrick S Western
Journal:  Nat Biotechnol       Date:  2019-01-03       Impact factor: 54.908

Review 7.  Sex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure.

Authors:  James Hester; Corey Ventetuolo; Tim Lahm
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

Review 8.  Deconstructing and reconstructing the mouse and human early embryo.

Authors:  Marta N Shahbazi; Magdalena Zernicka-Goetz
Journal:  Nat Cell Biol       Date:  2018-07-23       Impact factor: 28.824

Review 9.  Modeling human infertility with pluripotent stem cells.

Authors:  Di Chen; Joanna J Gell; Yu Tao; Enrique Sosa; Amander T Clark
Journal:  Stem Cell Res       Date:  2017-04-13       Impact factor: 2.020

10.  Long-term expansion with germline potential of human primordial germ cell-like cells in vitro.

Authors:  Yusuke Murase; Yukihiro Yabuta; Hiroshi Ohta; Chika Yamashiro; Tomonori Nakamura; Takuya Yamamoto; Mitinori Saitou
Journal:  EMBO J       Date:  2020-09-20       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.